Risikofaktoren für die Entstehung und den Verlauf der Schizophrenie

Gemäß dem derzeitigen Wissen entsteht eine Schizophrenie multifaktoriell – und zwar durch kumulative Wirkung einzelner, für sich unterschwelliger Risikofaktoren. Diese Faktoren (u. a. genetische, psychosoziale, umweltbedingte, prä- und peripartale) ziehen strukturelle Gehirnveränderungen und Veränderungen einzelner Neurotransmittersysteme nach sich, die schließlich zum Vollbild der Schizophrenie führen.

Schlüsselwörter

Schizophrenie - Entstehung - Risikofaktoren - Gen-Umwelt-Interaktion

• Literatur

• 1 McGrath J, Saha S, Chant D. et al. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008; 30: 67-76
• 2 Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-669
• 3 Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder?. Br Med J (Clin Res Ed) 1987; 295: 681-682
• 4 Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009; 35: 528-548
• 5 Davis J, Eyre H, Jacka FN. et al. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev 2016; 65: 185-194
• 6 Falkai P. Hrsg. Praxishandbuch Schizophrenie. München: Urban und Fischer/Elsevier; 2016
• 7 Janoutova J, Janackova P, Sery O. et al. Epidemiology and risk factors of schizophrenia. Neuro Endocrinol Lett 2016; 37: 1-8
• 8 Saha S, Chant D, Welham J. et al. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2: e141
• 9 Ripke S NB, Corvin A, Walters JT. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421-427
• 10 Hasan A, Malchow B, Falkai P. et al. [The glutamate hypothesis of schizophrenia]. Fortschr Neurol Psychiatr 2014; 82: 447-456
• 11 Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 2015; 29: 97-115
• 12 Schmitt A, Malchow B, Hasan A. et al. The impact of environmental factors in severe psychiatric disorders. Front Neurosci 2014; 8: 19
• 13 Kendler KS, Ohlsson H, Sundquist J. et al. IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry 2015; 172: 259-265
• 14 Markham JA, Koenig JI. Prenatal stress: role in psychotic and depressive diseases. Psychopharmacol (Berl) 2011; 214: 89-106
• 15 Boydell J. Risk factors for schizophrenia. Expert Rev Neurother 2001; 1: 183-191
• 16 Cannon TD, van Erp TG, Rosso IM. et al. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 2002; 59: 35-41
• 17 Gibson LE, Alloy LB, Ellman LM. Trauma and the psychosis spectrum: A review of symptom specificity and explanatory mechanisms. Clin Psychol Rev 2016; 49: 92-105
• 18 Corcoran CM, Smith C, McLaughlin D. et al. HPA axis function and symptoms in adolescents at clinical high risk for schizophrenia. Schizophr Res 2012; 135: 170-174
• 19 van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature 2010; 468: 203-212
• 20 Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry 2005; 162: 12-24
• 21 Vassos E, Agerbo E, Mors O. et al. Urban-rural differences in incidence rates of psychiatric disorders in Denmark. Br J Psychiatry 2016; 208: 435-440
• 22 Boden JM, van Stockum S, Horwood LJ. et al. Bullying victimization in adolescence and psychotic symptomatology in adulthood: evidence from a 35-year study. Psychol Med 2016; 46: 1311-1320
• 23 Stirling J. Schizophrenia and expressed emotion. Perspect Psychiatr Care 1994; 30: 20-25
• 24 Large M, Sharma S, Compton MT. et al. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555-561
• 25 Murray RM, Quigley H, Quattrone D. et al. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry 2016; 15: 195-204
• 26 Bossong MG, Niesink RJ. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 2010; 92: 370-385
• 27 Di Forti M, Marconi A, Carra E. et al. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry 2015; 2: 233-238
• 28 Murray RM, Englund A, Abi-Dargham A. et al. Cannabis-associated psychosis: Neural substrate and clinical impact. Neuropharmacology 2017; 124: 89-104
• 29 Schoeler T, Petros N, Di Forti M. et al. Association between continued cannabis use and risk of relapse in first-episode psychosis: A quasi-experimental investigation within an observational study. JAMA Psychiatry 2016; 73: 1173-1179
• 30 Muller-Vahl KR, Emrich HM. Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia. Expert Rev Neurother 2008; 8: 1037-1048